Clin2
NCT07516899Likely a fitNot yet recruiting

Study of an experimental drug in healthy men

Huntington Disease

Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.

This trial is for healthy men to see how the body processes an experimental drug. It will help researchers understand how the drug is absorbed, broken down, and removed from the body.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
8 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be a healthy man between 18 and 45 years old.
  • Your body mass index (BMI) must be between 19 and 26, and you must weigh at least 50 kg (about 110 pounds).
  • You must agree to use effective birth control and not donate sperm for 1 year after the trial.
  • You must not have taken any prescription or over-the-counter medications, herbal supplements, or vitamins within 4 weeks before the trial.
  • You must not smoke more than 5 cigarettes a day, drink more than 14 units of alcohol per week, or use recreational drugs.
  • You must be willing to stay in the clinic for the study and follow all the rules, including a special diet and avoiding strenuous exercise.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06634628Recruiting· Early Phase 1
Testing a new brain scan tracer for Huntington's disease

This trial tests a new radioactive tracer called [11C]CHDI-00491009 that may show mutant huntingtin protein in the brain using a PET scan. It aims to find out if the tracer is safe and helps see Huntington's disease changes. If you have early-stage Huntington's or are a healthy volunteer, you may be able to join.

Leuven
NCT07872579Not yet recruiting· Phase 1
Study of a new drug in healthy men

This study tracks how a new drug, called FXS4640, moves through the body in healthy men. It uses a small amount of radioactivity to follow the drug, which helps researchers understand how it is absorbed and cleared. Participation involves staying at the clinic for several days for tests and samples.

Wuxi, Jiangsu
NCT06701110Recruiting· Phase 1
Study of sudapyridine in healthy Chinese men

This trial tests how Sudapyridine (WX-081) moves through the body in healthy Chinese men. It helps researchers understand the drug's effects and safety before moving to later studies.

Suzhou, Jiangsu
NCT07656779Not yet recruiting· Phase 1
Study of drug breakdown in healthy men

This study looks at how a new medicine is broken down and removed from the body in healthy men. It helps researchers understand the drug's safety and how it works.

Wuxi, Jiangsu
NCT07764705Not yet recruiting· Phase 1
Study of a new drug in healthy men

This study is testing how a new drug is processed by the body in healthy men. It will help researchers understand the drug's effects and safety before it is tested in patients.

NCT07557407Not yet recruiting· Phase 1
Study of how a new drug is processed in healthy men

This study examines how a new drug (called HRS-1780) is processed and eliminated by the body using a special radioactive label. It will help researchers understand the drug’s behavior to guide future studies.

Jinan, Shandong

Hear when a new Huntington Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.